Drug Development

Articles

The license approval marks another milestone in Aptar Pharma’s ongoing service development to provide large-scale production services to customers.

Aptar Pharma Granted License to Deliver Preservative-Free Multi-Dose Systems to China

As the prevalence of falsified medicines continues to increase, Switzerland is taking measures to secure its supply chain such as the implementation of serialization.

DBV Technologies Receives FDA Breakthrough Therapy Designation for Peanut Allergy Treatment

Aptar Pharma has partnered with Shanghai Sine Promod Pharmaceutical to develop and launch its new budesonide dry powder inhaler (DPI), which features Aptar Pharma’s user-friendly and cost-effective Twister DPI.

Shanghai Sine Promod Pharmaceutical Chooses Aptar Pharma’s Twister DPI for Asthma Therapy

GlaxoSmithKline announces global vaccines research and design facility to be based in Rockville, MD, USA.

GSK Announces US Vaccine R&D Center

NIH announced positive safety results from the vaccine, VSV-ZEBOV, and found that all patients in the study experienced a strong antibody response.

NIH Announces Positive Results for Experimental Ebola Vaccine

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Emerging controlled-release technologies could lead to more effective therapies in the near future.

Will Advances in Controlled Release Open Up New Drug Delivery Opportunities?

James P. Agalloco is the president of Agalloco & Associates, P.O. Box 899, Belle Mead, NJ 08502, tel. 908.874.7558, jagalloco@aol.com. He is also a member of Pharmaceutical Technology’s editorial advisory board.

The Human Microbiome Project has increased our understanding of the relationship between humans and microorganisms. The authors offer a new perspective on how this knowledge should be considered in setting standards for pharmaceutical quality control in microbiology.

The Human Microbiome Project and Pharmaceutical Quality Control Microbiology

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

In this article, industry experts discuss critical analyses for demonstrating biosimilarity.

An Orthogonal Approach to Biosimilarity

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

FDA approves a biosimilar and loses a commissioner in March.

Welcome to the Biosimilar Era

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Multivariate data analysis (MVDA) is being used to effectively handle complex datasets generated by process analytical technology (PAT) in biopharmaceutical process development and manufacturing.

Formulation and Drug Delivery